The effectiveness and safety of subcutaneous immunotherapy for inhalable allergens in patients with respiratory allergies after one year of treatment. Rev Alerg Mex [Internet]. 2021 Feb. 9 [cited 2026 Sep. 25];67(4):309-15. Available from: https://ojs.revistaalergia.mx/ojs/index.php/ram/article/view/758